Thanks, Cliff. As we've done in the past, we are reporting both GAAP and non-GAAP numbers. I would like to point out that certain non-GAAP measures adjust for the Midas divestiture. This is similar to past practice. The reconciliations are in our filings and in the appendix of the presentation. Let's turn to Slide 5 and discuss our key sales metrics. Our primary sales metric, ACV, grew 3% for the quarter as compared to Q2 2021, when normalizing for onetime volumes in 2021, which included government stimulus. This was also up approximately 7% sequentially, and we now have posted sequential growth in this key sales metric for the past 4 quarters, evidencing our continued strong underlying sales performance. This sales performance was particularly strong in the Commercial segment with one of the highest levels of ACV signings since spin at $124 million. New business ARR was slightly down and the new business TCV for the quarter was impacted by an unfavorable compare from Q2 2021 when we signed large long-term deals with Highways England in the Transportation segment and New Hampshire Department of Health and Human Services in the Government segment. The net ARR activity metric, our combined measure of wins, losses, pricing effect and other contractual changes was positive for the second quarter. As a reminder, this trailing 12-month measure does not predict the timing of revenue but is based on the timing of notification, and such will fluctuate from quarter-to-quarter. Finally, the quality of our sales pipeline remains very healthy, and we have the highest value of late-stage pipeline since the third quarter of 2017 with strong coverage across all 3 segments. Let's now turn to Slide 6 and discuss some of the key sales metric trends. As I mentioned earlier, our trend on new business ACV, our primary sales metric, is encouraging, with ACV increasing sequentially for the past 4 quarters. Our TCV will fluctuate significantly quarter-to-quarter as we have said in the past, given the change in mix of deals between segments. Commercial segment deals average between 3 and 4 years whereas Government and Transportation segment deals are typically much longer in duration. This drives a lot of the variability in TCV as well as average contract length. Q2 was a quieter quarter for renewals after significant renewal activity in the 2 prior quarters. Our renewal rate remains extremely strong. Now let's turn to Slide 7 and discuss our Q2 2022 financial results. Overall, as Cliff mentioned earlier, Q2 finished right in line with where we expected it and where we guided to when we laid out our expectations for you during our Q1 earnings call, especially considering the unfavorable exchange rates impacting our international transit and European commercial businesses. This was a $3 million revenue headwind against that guidance during the quarter and an overall $11 million revenue headwind when compared with Q2 2021. In terms of the numbers themselves, adjusted revenue for Q2 2022 was $928 million as compared to $1 billion in Q2 2021, down 8% year-over-year or 6.9% in constant currency. The year-over-year headwind from the roll-off of onetime government stimulus volumes from 2021 in the quarter was $59 million. And as we told you in Q1 earnings, the year-over-year as well as the sequential trend was impacted as expected by a financial institution client merger that rolled off revenue in the quarter within our Commercial segment. Adjusted EBITDA was $87 million for the quarter, down 26.9% as compared to Q2 2021, and the adjusted EBITDA margin of 9.4% was down 240 basis points year-over-year. Again, this was in line with our internal expectations and how we laid out guidance for margin progression for the year in our Q4 2021 earnings call in February. As I'll discuss later in the presentation, when we look at the full year guidance, Q2 is the low point of our year in terms of both revenue and margin with one more quarter remaining, where we are lapping the significant headwind from the onetime government stimulus volumes, but as we go later into the year, our revenue ramp reduces this effect. Let's now turn to Slide 8, and go over the segment results. For Q2 2022, Commercial segment adjusted revenues were down 3.7% year-over-year at $470 million due largely to the previously mentioned financial institution merger impact. There were also negative impacts from foreign exchange in our European business, and these were partially offset with strong new business ramp. Adjusted EBITDA for the quarter was $46 million, up 9.5% as compared to Q2 2021. Adjusted EBITDA margin was 9.8%, up 120 basis points. Both reflected the impact of mix from higher interest rates, which positively impacted our BenefitWallet business as well as cost efficiency programs that we used to offset other expense headwinds. Within the Government segment, adjusted revenues for the quarter were $279 million, down 17% year-over-year as compared to Q2 2021. The year-over-year impact of the runoff of government stimulus revenue was $59 million in the quarter. Removing that impact, the underlying base business would have been slightly higher year-over-year. Adjusted EBITDA for the Government segment in Q2 2022 was $78 million, down approximately 34% year-over-year, reflecting that runoff of government stimulus volumes, partially offset by operational efficiency initiatives. The adjusted EBITDA margin of 28% was down 710 basis points year-over-year. Transportation segment revenues in Q2 2022 were $179 million, down approximately 3% year-over-year. Our international transit business within the Transportation segment had approximately $5 million of headwind from foreign exchange as compared to the prior year. And adjusting for that, we were essentially flat year-over-year, which was in line with our expectations, and again, consistent with how we laid it out for you in the Q1 earnings call. For the Transportation segment, adjusted EBITDA for the quarter was $24 million, down 4% as compared to Q1 2021, and the adjusted EBITDA margin was 13.4%, down 10 basis points year-over-year. Let's now turn to Slide 9 and discuss the balance sheet and cash flow. Our cash position remains healthy. We ended the quarter with $530 million in cash on the balance sheet and a net leverage ratio of 1.8 turns, which is below what we believe is our normalized range of 2 to 2.5 turns. Capital expenditure as a percentage of revenue decreased during the quarter to 3.6%, and we expect that sequential decline to continue through Q3 and Q4 as we have somewhat front-loaded our investment plans to drive revenue into the back half of 2022 and beyond. Working capital increases during the quarter addressed the need to ensure supply chain timeliness and support our strong implementation ramp in the second half of the year. We expect many of these items to reverse during the second half of the year. Additionally, higher collections in the latter half of the year keeps us on course to achieve our full year outlook for adjusted free cash flow. Let's turn to Slide 10 and review our 2022 guidance. We are updating our guidance for adjusted revenues in 2022 to be in the range of $3.85 billion to $3.95 billion. As we move into the second half of the year, we see increased confidence in narrowing this range with the following assumptions. We have baked in last week's 75 basis point hike in Fed rates. And against our original guide, this benefits in-year revenue by approximately $12 million. As a reminder, we will see much more benefit from this in 2023 as these increases in rates fully annualize within our 2023 numbers. We are also including in this guide the impacts of foreign exchange on our international transit and European commercial businesses, which we currently expect to be an approximate $20 million headwind for the full year against our original revenue guidance. The overall midpoint of our revenue guidance remains unchanged, and we continue to expect the Commercial and Transportation segments to achieve full year growth on a constant currency basis. When adjusting for foreign exchange headwinds, the Commercial and Transportation segments will grow approximately 1% and 3% year-over-year, respectively, which is in line with the segment-level trajectories we laid out at the beginning of the year. One of the key planks of our turnaround strategy has been to return the Commercial segment, our largest business, to a trajectory of sustained constant currency growth. During the second half of the year, the Commercial segment will grow approximately 1.5% year-over-year as compared to the second half of 2021 and, as noted above, we expect approximately 1% of growth for the full year 2022 as compared to 2021 in constant currency. Underpinning this turnaround has been an intense focus on all aspects of quality for our clients, which has brought increasing stability to our revenue base. Additionally, we saw in the second quarter of 2022 one of the highest ever quarters of ACV sales attainment in the Commercial segment, which is driving our ramp in the second half of the year and into 2023. Baked into the above outlook for the Commercial segment is an expectation that a couple of our larger commercial clients are experiencing a level of normalization in their post-pandemic call volumes. We have this included in our 2022 guidance as an approximate $25 million to $30 million headwind this year and likely a $35 million to $40 million headwind in 2023 as far as we see it at this point. I'll talk more about how these effects fit into our 2023 outlook when we get together later in the year. But to reiterate for now, this 2022 effect is contemplated in how we're thinking about the guidance we've just laid out. Finally, as we think about our segments for 2022, we are now expecting the Government segment to perform better than our original guidance. We now expect the year-over-year decline to be around 13%, which, ignoring the onetime benefit from government stimulus programs in 2021, would have the underlying business growing slightly in 2022 where previously we expected it to be flat. The drivers behind this are an expected elevated level of post-pandemic volumes in our SNAP programs and slightly better retention. We also have a very strong pipeline of late-stage deals in our Government health care business. We are updating our adjusted EBITDA guidance for 2022 to be in the range of 10% to 10.5%. The drivers are the mix of business, stronger contribution from higher interest rate expectations noted earlier, along with ongoing cost initiatives across businesses and functions. We still expect to convert approximately 15% of adjusted EBITDA to adjusted free cash flow, inclusive of paying off the remaining portion of deferred payroll taxes under the CARES Act. Similarly, we are not changing our outlook on CapEx or restructuring charges. As we did last quarter, I'll lay out the revenue and margin expectations for the coming quarter. We see adjusted revenue in the range of $970 million to $985 million for the third quarter and adjusted EBITDA margin towards the midpoint of our full year guided range. That concludes our financial review for Q2 2022, and I'll hand it back to Cliff now for closing comments. Cliff?